Dashboard
Discussions
Watchlists
Collections
More
Events
Tools
SIGN UP
SIGN IN
bearish
Beijing Wantai Biological Phar
Watchlist
Beijing Wantai Biological (603392.CH) - How to Support Its High Valuation?
This article mainly analyzed Wantai in terms of the two core business IVD and HPV vaccine, their business outlook, the market pattern and the related concerns.
Equity Bottom-Up
181 Views
15 Jul 2021 09:36
SUMMARY
(Sign Up to Access)
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
Unlimited Research Summaries
Personalised Alerts
Custom Watchlists
Company Analytics & News
Events & Webinars
Trusted by:
SMARTKARMA PREVIEW PASS
Sign Up with LinkedIn
or
First Name
Last name
Email
Sign Up with Email
By signing up, you agree to our
Terms of Use
and
Privacy Policy
.
Trusted by:
Already have an account?
Sign In Now
Full Insight
(Paid Plans Only)
Discussions
(Paid Plans Only)
Top Quartile
Xinyao (Criss) Wang
HK/China Healthcare Analyst (ex-Fosun Pharma)
China
Health Care
Equity Bottom-Up
Thematic (Sector/Industry)
View Full Profile
Price Chart
(Sign Up to Access)
Insight Stream
China Healthcare Weekly (July.30)
01 Aug 2021
China Healthcare Weekly (July.23)
25 Jul 2021
China Healthcare Weekly (July.16)
18 Jul 2021
Beijing Wantai Biological (603392.CH) - How to Support Its High Valuation?
15 Jul 2021
Autobio Diagnostics (603658.CH) - The Turning Point Is Quietly Approaching
03 May 2021
Chongqing Zhifei Biological Products (300122.CH) - Could Zhifei Support Its Valuation?
26 Apr 2021
Beijing Wantai Biological (603392.CH) - After A 3839% Rally, Let's Look at Some Concerns
28 Feb 2021
Top
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.18.2
x